言語を選択

DRD1

DRD1 詳細

英語名	Dopamine D1 receptor	市販薬剤の数	10
治験薬の数	15	ターゲットの別称	D(1A) dopamine receptor，DRD1，Dopamine Receptor D1，Dopamine D1 Receptor，DRD1A，DADR，Receptors， Dopamine D1
研究＆開発段階	Approved

英語名	Dopamine D1 receptor
ターゲットの別称	D(1A) dopamine receptor，DRD1，Dopamine Receptor D1，Dopamine D1 Receptor，DRD1A，DADR，Receptors， Dopamine D1
市販薬剤の数	10
治験薬の数	15
研究＆開発段階	Approved

DRD1 製品リスト

属性
Protein (1)
製品ライブラリ
オンライン (1)
種
Human (1)
タグ
- (1)
マーカー
Unconjugated (1)

製品番号	種	発現システム	製品説明	タンパク質の構造	純度	特性
DR1-H52P6	Human	HEK293	Human DRD1 Full Length Protein (VLP)

総数量1

DRD1バックグランド

The dopamine receptor D1 (Drd1) is a member of the D1-like receptor family and is the most abundant dopamine receptor in the central nervous system. The receptor is found in the cortex, striatum and limbic system of the brain and the cardiovascular system.

DRD1分子の別称

DRD1,Dopamine D1 receptor,D1R; DADR; DRD1A

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
Ecopipam	PSYRX-101; Sch-39166	Phase 3 Clinical	Merck Sharp & Dohme Corp	Childhood-Onset Fluency Disorder; Gambling; Language Disorders; Lesch-Nyhan Syndrome; Self-Injurious Behavior; Speech Disorders; Stuttering; Tourette Syndrome	詳細
Olanzapine transdermal patch (Starton Therapeutics)	CMIO-OLANZ; CHEMIO OLANZ; CMIO-OLNZ; STAR-OLZ	Phase 3 Clinical	Starton Therapeutics Inc	Nausea; Vomiting	詳細
Olanzapine/samidorphan (Qilu Pharmaceutical)		Phase 3 Clinical	Qilu Pharmaceutical Co Ltd	Schizophrenia	詳細
PF-06412562	PF-6412562; PF-06412562; PF-2562; CVL-562	Phase 2 Clinical	Pfizer Inc	Parkinson Disease; Schizophrenia; Schizophrenia Spectrum and Other Psychotic Disorders	詳細
Mevidalen	LY-3154207	Phase 2 Clinical	Eli Lilly And Company	Alzheimer Disease; Lewy Body Disease; Parkinson Disease	詳細
TGOF02N	TGOF-02N; TGOF02N; FKF02SC	Phase 2 Clinical	Fabre-Kramer	Schizophrenia	詳細
Docarpamine (Martin Pharmaceuticals)		Phase 2 Clinical	Martin Pharmaceuticals Inc	Gastrointestinal Diseases; Liver Cirrhosis; Mouth Diseases	詳細
Glovadalen	UCB-0022	Phase 2 Clinical	Ucb Biopharma Srl	Parkinson Disease	詳細
[11C]NNC-112	[11C]NNC-112	Phase 2 Clinical	Glaxosmithkline Plc	Diagnostic agents	詳細
Lu-AF-28996		Phase 1 Clinical	H. Lundbeck A/S	Parkinson Disease	詳細
asenapine schizophrenia (Livzon Pharmaceutical/LTS Lohmann Therapie-Systeme)		Phase 1 Clinical	Lts Lohmann Therapie-Systeme Ag	Schizophrenia	詳細
Olanzapine intranasal (Neurelis)	NRL-4; NRL-1004	Phase 1 Clinical	Neurelis Inc	Bipolar Disorder	詳細
Oxytocin/Methylergometrine Maleate		Phase 1 Clinical	Nanjing Gritpharma Co Ltd	Hemorrhage; Obstetric Labor Complications	詳細
ITI-333	ITI-333	Phase 1 Clinical	Intra-Cellular Therapies Inc	Mood Disorders; Opioid-Related Disorders; Pain	詳細
PF-06730110	PF-06730110; [18F]MNI-968	Phase 1 Clinical	Invicro Llc	Nerve Degeneration	詳細

市販薬剤に関する情報

英語名	研究コード	研究開発ステージ	会社	オリジナル製品名	最初に承認をした国	最初の適応症	最初に承認を受けた会社	承認された日付	適応症	臨床試験
Docarpamine	TA-870; TA-8704	Approved		Tanadopa		Heart Failure	null	1994-01-01	Heart Failure	詳細
Olanzapine/Fluoxetine hydrochloride	OFC	Approved	Eli Lilly And Company	Symbyax	Mainland China	Bipolar I Disorder	Jiangsu Changtai Pharmaceutical Co Ltd	2003-12-24	Bipolar Disorder; Bipolar I Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant	詳細
Zuclopenthixol Hydrochloride	LU-0108	Approved		Clopixol		Bipolar Disorder; Schizophrenia	null	1962-01-01	Bipolar Disorder; Schizophrenia	詳細
Methylergometrine Maleate		Approved		Metenarin, Methergine, Ryegonivin, Basofortina, Methylergobrevin	Japan	Postpartum Hemorrhage	Aska Pharmaceutical Co Ltd	1971-05-01	Postpartum Hemorrhage; Uterine Cervical Incompetence; Uterine Hemorrhage; Uterine Inertia	詳細
Samidorphan/Olanzapine	ALKS-3831	Approved	Alkermes Plc	Lybalvi	United States	Bipolar Disorder; Schizophrenia	Alkermes Inc	2021-05-28	Alcoholism; Bipolar and Related Disorders; Bipolar Disorder; Bipolar I Disorder; Psychotic Disorders; Schizophrenia	詳細
Olanzapine	ALKS-7921; LY-170052; LY-170053; INP-105; BR-5402; QLG-2072; QLG2072	Approved	Eli Lilly And Company	Zyprexa Zydis, Zyprexa Relprevv, Olansek, Zalasta, Zyprexa, Zyprexa Velotab, Olanzapine ODF, Lanzac, Zypadhera, 再普乐, Midax	EU	Bipolar Disorder; Schizophrenia	null	1996-09-27	Anorexia; Anorexia Nervosa; Autistic Disorder; Biliary Tract Neoplasms; Bipolar Disorder; Bipolar I Disorder; Bipolar II Disorder; Borderline Personality Disorder; Cachexia; Carcinoma, Hepatocellular; Chemotherapy-induced nausea and vomiting; Colorectal Neoplasms; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Emergence Delirium; Esophageal Neoplasms; Fasting; Feeding and Eating Disorders; Gambling; Hematopoietic stem cell transplantation (HSCT); Insulin Resistance; Lung Neoplasms; Malaria, Falciparum; Multiple Myeloma; Nausea; Neoplasms; Opioid-Related Disorders; Postoperative Nausea and Vomiting; Schizophrenia; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Substance-Related Disorders; Tinnitus; Vomiting; Weight Loss	詳細
Phenylpropanolamine Hydrochloride		Approved		Nasadec, Nasathera, Pararhinol					Nasal Obstruction	詳細
Olanzapine Oral Soluble Film(Jiangsu Hansoh)		Approved	Jiangsu Hansoh Pharmaceutical Group Co Ltd		Mainland China	Schizophrenia; Bipolar Disorder	Jiangsu Hansoh Pharmaceutical Group Co Ltd	2020-11-24	Bipolar Disorder; Schizophrenia	詳細
Olanzapine Oral Soluble Film(Qilu Pharma)		Approved	Qilu Pharmaceutical Co Ltd		Mainland China	Bipolar Disorder; Schizophrenia	Qilu Pharmaceutical Co Ltd	2021-01-19	Bipolar Disorder; Schizophrenia	詳細
Stepholidine		Approved			Mainland China	Attention Deficit Disorder with Hyperactivity; Tourette Syndrome; Migraine Disorders; Headache	null	1995-01-01	Attention Deficit Disorder with Hyperactivity; Headache; Migraine Disorders; Tourette Syndrome	詳細